Reassessment of motor-behavioural test analyses enables the detection of early disease-onset in a transgenic mouse model of amyotrophic lateral sclerosis

Behavioural Brain Research

Volumn 225, Issue 1, 2011, Pages 7-14

  Schäfer, Sabrina ^a,b   Hermans, Emmanuel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b European Graduate School of Neuroscience   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Break point analysis; Grip strength; HSOD1 G93A; Mouse model; Open field

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREAK POINT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FUNCTION TEST; GRIP STRENGTH; HINDLIMB; INTERMETHOD COMPARISON; MALE; MOTOR BEHAVIORAL TEST; MOUSE; NEUROLOGIC EXAMINATION; NEWBORN; NONHUMAN; ONSET AGE; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SYMPTOM; WEIGHT REDUCTION;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; HAND STRENGTH; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; SEX FACTORS; SUPEROXIDE DISMUTASE;

EID: 79960317823     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.06.019     Document Type: Article

References (29)

1. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004, 27:723-749.
2. Gurney M.E., Pu H.F., Chiu A.Y., Dalcanto M.C., Polchow C.Y., Alexander D.D., et al. Motor-neuron degeneration in mice that express a human Cu, Zn superoxide-dismutase mutation. Science 1994, 264:1772-1775.
3. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996, 13:43-47.
4. Wood J.D., Beaujeux T.P., Shaw P.J. Protein aggregation in motor neurone disorders. Neuropathol Appl Neurobiol 2003, 29:529-545.
5. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M.S., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004, 185:232-240.
6. Matsumoto A., Okada Y., Nakamichi M., Nakamura M., Toyama Y., Sobue G., et al. Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res 2006, 83:119-133.
7. Vargas M.R., Johnson J.A. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics 2010, 7:471-481.
8. Durand J., Amendola J., Bories C., d'Incamps B.L. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis. J Physiol Paris 2006, 99:211-220.
9. de Hemptinne I., Boucherie C., Pochet R., Bantubungi K., Schiffmann S.N., Maloteaux J.M., et al. Unilateral induction of progenitors in the spinal cord of hSOD1(G93A) transgenic rats correlates with an asymmetrical hind limb paralysis. Neurosci Lett 2006, 401:25-29.
10. Liebetanz D., Hagemann K., von Lewinski F., Kahler E., Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 2004, 20:3115-3120.
11. Muggeo V.M. Estimating regression models with unknown break-points. Stat Med 2003, 22:3055-3071.
12. Smittkamp S.E., Brown J.W., Stanford J.A. Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice. Neuroscience 2008, 151:613-621.
13. Toms J.D., Lesperance M.L. Piecewise regression: a tool for identifying ecological thresholds. Ecology 2003, 84:2034-2041.
14. Vanak A.T., Thaker M., Slotow R. Do fences create an edge-effect on the movement patterns of a highly mobile mega-herbivore?. Biol Conserv 2010, 143:2631-2637.
15. Nau K.L., Bromberg M.B., Forshew D.A., Katch V.L. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 1995, 129(Suppl.):47-49.
16. Silani V., Kasarskis E.J., Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurol 1998, 245(Suppl. 2):S13-S19.
17. Alves C.J., de Santana L.P., Santos A.J., de Oliveira G.P., Duobles T., Scorisa J.M., et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res 2011, 1394:90-104.
18. Hayworth C.R., Gonzalez-Lima F. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. Neuroscience 2009, 164:975-985.
19. Weydt P., Hong S.Y., Kliot M., Moller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003, 14:1051-1054.
20. Del Signore S.J., Amante D.J., Kim J., Stack E.C., Goodrich S., Cormier K., et al. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotroph Lateral Scler 2009, 10:85-94.
21. Morrison B.M., Lachey J.L., Warsing L.C., Ting B.L., Pullen A.E., Underwood K.W., et al. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 2009, 217:258-268.
22. Lepore A.C., Tolmie C., O'Donnell J., Wright M.C., Dejea C., Rauck B., et al. Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats. Neurobiol Dis 2010, 39:252-264.
23. McCombe P.A., Henderson R.D. Effects of gender in amyotrophic lateral sclerosis. Gend Med 2010, 7:557-570.
24. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 2003, 13:737-743.
25. Suzuki M., Tork C., Shelley B., McHugh J., Wallace K., Klein S.M., et al. Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler 2007, 8:20-25.
26. Knippenberg S., Thau N., Dengler R., Petri S. Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res 2010, 213:82-87.
27. Heiman-Patterson T.D., Deitch J.S., Blankenhorn E.P., Erwin K.L., Perreault M.J., Alexander B.K., et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci 2005, 236:1-7.
28. Heiman-Patterson T.D., Sher R.B., Blankenhorn E.A., Alexander G., Deitch J.S., Kunst C.B., et al. Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: a window of opportunity in the search for genetic modifiers. Amyotroph Lateral Scler 2011, 12:79-86.
29. Herbik M.A., Chrapusta S.J., Kowalczyk A., Grieb P. Maintenance of the rat transgenic model of familial amyotrophic lateral sclerosis expressing human SOD1G93A mutation. Folia Neuropathol 2006, 44:149-153.